Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis.
Nicolas GirardMariam BesadaBasia RogulaStefano LucheriniLien VoMohammad A ChaudharySarah GoringGreta Lozano-OrtegaMia TranNebibe VarolNathalie A WaserJay M LeeJonathan D SpicerPublished in: Cancers (2024)
This NMA signals improved EFS and/or pCR of neoNIVO + CT relative to comparators among patients with rNSCLC.